| Title: | Exploring the relationship of genetics, proteins, metabolites and other biomarkers with clinical endpoints |
| Lead Institution: | 23andMe, Inc. |
| Principal investigator: |
Application 95801
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Blood-based biomarkers including metabolites and proteins may be important in disease. We wish to use conventional and cutting-edge analyses to better understand the role that these biomarkers have in disease. We also want to better understand the relationship of genetic variants combined into a score exhibit with biomarkers and disease.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 18060 | Genetic predictors of GLP1 receptor agonist weight loss and side effects | Qiaojuan Jane Su (+12) | 2026 | Nature |
Enabling scientific discoveries that improve human health